Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-009499
Filing Date
2025-09-03
Accepted
2025-09-03 18:36:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27749
2 filename2.txt TEXT-EXTRACT 1216
  Complete submission text file 0000000000-25-009499.txt   40293
Mailing Address 256 E. GRAND AVENUE, SUITE 104 SOUTH SAN FRANCISCO CA 94080
Business Address 256 E. GRAND AVENUE, SUITE 104 SOUTH SAN FRANCISCO CA 94080 857 702 0377
BridgeBio Oncology Therapeutics, Inc. (Filed for) CIK: 0001869105 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-289940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)